TY - JOUR
T1 - Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards
T2 - data from the RePoSI Registry
AU - the REPOSI Investigators
AU - Argano, Christiano
AU - Scichilone, Nicola
AU - Natoli, Giuseppe
AU - Nobili, Alessandro
AU - Corazza, Gino Roberto
AU - Mannucci, Pier Mannuccio
AU - Perticone, Francesco
AU - Corrao, Salvatore
AU - Pietrangelo, Antonello
AU - Licata, Giuseppe
AU - Violi, Francesco
AU - Marengoni, Alessandra
AU - Salerno, Francesco
AU - Cesari, Matteo
AU - Tettamanti, Mauro
AU - Pasina, Luca
AU - Franchi, Carlotta
AU - Miglio, Gabriella
AU - Cortesi, Laura
AU - Ardoino, Ilaria
AU - Novella, Alessio
AU - Prisco, Domenico
AU - Silvestri, Elena
AU - Emmi, Giacomo
AU - Bettiol, Alessandra
AU - Caterina, Cenci
AU - Biolo, Gianni
AU - Zanetti, Michela
AU - Guadagni, Martina
AU - Zaccari, Michele
AU - Chiuch, Massimiliano
AU - Zaccari, Michele
AU - Vanoli, Massimo
AU - Grignani, Giulia
AU - Pulixi, Edoardo Alessandro
AU - Bernardi, Mauro
AU - Bassi, Silvia Li
AU - Santi, Luca
AU - Zaccherini, Giacomo
AU - Lupattelli, Graziana
AU - Mannarino, Elmo
AU - Bianconi, Vanessa
AU - Paciullo, Francesco
AU - Alcidi, Riccardo
AU - Nuti, Ranuccio
AU - Valenti, Roberto
AU - Ruvio, Martina
AU - Cappelli, Silvia
AU - Pirisi, Mario
AU - Sola, Daniele
N1 - Publisher Copyright:
© 2020, Società Italiana di Medicina Interna (SIMI).
PY - 2021/3/1
Y1 - 2021/3/1
N2 - Currently, chronic obstructive pulmonary disease (COPD) represents the fourth cause of death worldwide with significant economic burden. Comorbidities increase in number and severity with age and are identified as important determinants that influence the prognosis. In this observational study, we retrospectively analyzed data collected from the RePoSI register. We aimed to investigate comorbidities and outcomes in a cohort of hospitalized elderly patients with the clinical diagnosis of COPD. Socio-demographic, clinical characteristics and laboratory findings were considered. The association between variables and in-hospital, 3-month and 1-year follow-up were analyzed. Among 4696 in-patients, 932 (19.8%) had a diagnosis of COPD. Patients with COPD had more hospitalization, a significant overt cognitive impairment, a clinically significant disability and more depression in comparison with non-COPD subjects. COPD patients took more drugs, both at admission, in-hospital stay, discharge and 3-month and 1-year follow-up. 14 comorbidities were more frequent in COPD patients. Cerebrovascular disease was an independent predictor of in-hospital mortality. At 3-month follow-up, male sex and hepatic cirrhosis were independently associated with mortality. ICS-LABA therapy was predictor of mortality at in-hospital, 3-month and 1-year follow-up. This analysis showed the severity of impact of COPD and its comorbidities in the real life of internal medicine and geriatric wards.
AB - Currently, chronic obstructive pulmonary disease (COPD) represents the fourth cause of death worldwide with significant economic burden. Comorbidities increase in number and severity with age and are identified as important determinants that influence the prognosis. In this observational study, we retrospectively analyzed data collected from the RePoSI register. We aimed to investigate comorbidities and outcomes in a cohort of hospitalized elderly patients with the clinical diagnosis of COPD. Socio-demographic, clinical characteristics and laboratory findings were considered. The association between variables and in-hospital, 3-month and 1-year follow-up were analyzed. Among 4696 in-patients, 932 (19.8%) had a diagnosis of COPD. Patients with COPD had more hospitalization, a significant overt cognitive impairment, a clinically significant disability and more depression in comparison with non-COPD subjects. COPD patients took more drugs, both at admission, in-hospital stay, discharge and 3-month and 1-year follow-up. 14 comorbidities were more frequent in COPD patients. Cerebrovascular disease was an independent predictor of in-hospital mortality. At 3-month follow-up, male sex and hepatic cirrhosis were independently associated with mortality. ICS-LABA therapy was predictor of mortality at in-hospital, 3-month and 1-year follow-up. This analysis showed the severity of impact of COPD and its comorbidities in the real life of internal medicine and geriatric wards.
KW - 1-year mortality
KW - 3-month mortality
KW - COPD, comorbidities, elderly, internal medicine, in-hospital mortality
UR - https://www.scopus.com/pages/publications/85096060138
U2 - 10.1007/s11739-020-02412-1
DO - 10.1007/s11739-020-02412-1
M3 - Article
SN - 1828-0447
VL - 16
SP - 389
EP - 400
JO - Internal and Emergency Medicine
JF - Internal and Emergency Medicine
IS - 2
ER -